pulmonary nodule
Conditions
Interventions
Waitlist group:No intervention was administered during the study period
Sponsors
Hubei Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1:Patients who met the diagnostic criteria for pulmonary nodules and were confirmed with pulmonary nodules with nodule diameter =5 mm. For multiple nodules the highest-risk nodule was selected as the observation point. In this study the highest-risk nodular lesion was used as the evaluation indicator for treatment efficacy. 2:Aged 18 to 80 years 3:Signed informed consent
Exclusion criteria
Exclusion criteria: 1:pregnant or lactating women 2:patients with severe organ failure (e.g. heart brain lung or kidney) or other primary diseases significantly affecting survival 3:the pulmonary nodule was identified as malignant during early-stage examination 4:patients with severe psychiatric disorders who are unable to comply with the study protocols 5:Patients with local skin damage or temperature sensory impairment patents with severe yin deficiency and fire prospenty syndrome real heat syndrome andpatients who are allergic to ginger juice and moxa smoke 6:Patients currently participating in other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy criteria for pulmonary nodule diameter reduction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Mayo Risk Probability;Generalised Anxiety Disorder Scale;European Five-Dimensional Health Scale;Beck Depression Inventory; | — |
Countries
China
Contacts
Public ContactWei Huang
Hubei Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed